Skip to content

A preliminary study to evaluate effectiveness of Korean medicine treatment for periodontal disease

A preliminary study to evaluate patient outcomes, feasibility, preliminary effectiveness, safety and economic evaluation of Korean medicine treatment for periodontal disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009294
Enrollment
45
Registered
2024-03-29
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Behavioral : 1. Acupuncture Treatment Group: Using a disposable needle with a thickness of 0.30mm and a length of 30.00mm, acupuncture will be applied to points within 10 locations, in

Sponsors

Dongguk University Ilsan Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Individuals aged 20 years and above but below 65 years, regardless of gender. (2) Those diagnosed with gingivitis and mild periodontitis. (3) Individuals who voluntarily provided written consent to this human application trial through the Informed Consent Form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe or advanced periodontitis. (2) Individuals who have undergone scaling and preventive periodontal treatment within the last 3 months from the date of consent form completion. (3) Smokers. (4) Individuals with orthodontic appliances. (5) Those with pathological findings in the oral tissues or requiring treatment from other departments. (6) Individuals requiring immediate treatment for dental caries. (7) Individuals with uncontrolled chronic conditions such as diabetes, liver disease, heart disease, kidney disease, bleeding disorders, or other chronic illnesses. (8) Those with clinically significant immune, infectious, neoplastic, or psychiatric disorders requiring treatment. (9) Users of medications that may affect periodontal health (nifedipine, phenytoin, cyclosporine). (10) Those who have taken antibiotics within the last 4 weeks, are currently taking antibiotics, or are planning to receive antibiotics in the future. (11) Individuals who have received investigational drugs or non-investigational medicinal products for clinical trials within 30 days prior to participating in the clinical trial. (12) Pregnant or lactating women, or fertile women not using acceptable contraceptive methods. (13) Individuals deemed unsuitable as subjects for this trial by the clinical trial investigator and personnel for reasons other than those mentioned above.

Design outcomes

Primary

MeasureTime frame
Clinical outcomes(VAS, PD, BOP, GI, PI, EQ-5D-5L)

Secondary

MeasureTime frame
Feasibility Outcomes ("Recruitment Rate, Adherence Rate, Completion Rate);Economic Evaluation Indicators (Incremental Cost-Utility Ratio and Incremental Cost-Effectiveness Ratio between the Test Group and Control Group)

Countries

Korea, Republic of

Contacts

Public ContactHeekyung Lee

Dongguk University Gyeongju Campus

baby8119@naver.com+82-2-961-9111

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026